GlycoMimetics, Inc. (GLYC)
NASDAQ: GLYC · Real-Time Price · USD
0.236
-0.019 (-7.44%)
At close: Dec 27, 2024, 4:00 PM
0.250
+0.014 (5.75%)
After-hours: Dec 27, 2024, 5:54 PM EST
GlycoMimetics Market Cap
GlycoMimetics has a market cap or net worth of $15.24 million as of December 27, 2024. Its market cap has decreased by -86.55% in one year.
Market Cap
15.24M
Enterprise Value
1.79M
1-Year Change
-86.55%
Ranking
Category
Stock Price
$0.24
Market Cap Chart
Since January 10, 2014, GlycoMimetics's market cap has decreased from $158.18M to $15.24M, a decrease of -90.36%. That is a compound annual growth rate of -19.21%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Acurx Pharmaceuticals | 15.57M |
| Adagio Medical Holdings | 15.55M |
| Cingulate | 15.52M |
| bioAffinity Technologies | 15.12M |
| ProPhase Labs | 15.10M |
| Aptose Biosciences | 15.10M |
| Streamline Health Solutions | 14.44M |
| ImmunoPrecise Antibodies | 13.83M |